Sign In
Buy XBI
$145.86
+5.14 (+3.65%)
At Close: Jun 22, 2026
Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar.
10:05am, Saturday, 20'th Jun 2026
Markets are hunting for new leadership as the Big Tech engine sputters, and one Wall Street technician thinks she knows where the baton is being passed.
XBI: A "Hidden" ETF Up +70% In 1 Year.
09:40am, Saturday, 20'th Jun 2026
State Street SPDR S&P Biotech ETF (XBI) has delivered over 75% 1-year performance, driven by equal-weight exposure to volatile small- and mid-cap biotech stocks. XBI's high beta profile offers strong
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?
03:46pm, Wednesday, 17'th Jun 2026
iShares U.S. Pharmaceuticals ETF offers a significantly higher dividend yield and lower volatility than State Street SPDR S&P Biotech ETF. While State Street SPDR S&P Biotech ETF delivered stronger 1-
Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC
01:00am, Tuesday, 16'th Jun 2026
Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-trac
Healthcare ETFs: From Broad Exposure to Big Breakthroughs
07:14am, Thursday, 11'th Jun 2026
With AI and space dominating many of the market's most popular investment themes, it can be difficult to find differentiated opportunities. Healthcare is often viewed as one of the more defensive sect
3 Longevity ETFs to Buy and Hold (and Hold)
07:40am, Monday, 08'th Jun 2026
Longevity is, increasingly, a big business. Advances in healthcare technology and AI have prompted both prominent medical professionals and individual investors to imagine how people might live longer
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech
08:45am, Friday, 05'th Jun 2026
Compare risk profiles, dividend strategies, and portfolio concentration as these two healthcare ETFs take different paths to long-term returns.
‘Buying stuff like it's going out of fashion': Biotech M&A on track for best year since pre-Covid
01:45am, Thursday, 04'th Jun 2026
So far in 2026, biotech deals amounted to $106 billion over 201 transactions, according to PitchBook data. That momentum in dealmaking comes despite an interest rate environment that has turned for th
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost
08:07am, Thursday, 28'th May 2026
Expense ratios, yield, and sector breadth set these healthcare ETFs apart-see how their risk profiles and portfolio strategies compare.
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
07:20am, Wednesday, 27'th May 2026
Making its debut on 01/31/2006, smart beta exchange traded fund State Street SPDR S&P Biotech ETF (XBI) provides investors broad exposure to the Health Care ETFs category of the market.
Biotech Investors Are Tuning Out the MAHA Chaos
05:30am, Wednesday, 20'th May 2026
The Food and Drug Administration is still in turmoil, but Wall Street no longer cares.
If You Hold This Healthcare ETF, You're Losing Big
11:12am, Tuesday, 19'th May 2026
The Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) is down about 5% year to date while the S&P 500 is up 7%.
SPDR S&P Biotech ETF (XBI) Price Forecast: Long-Term Breakout Fuels Biotech Strength
05:07pm, Friday, 08'th May 2026
XBI continues to strengthen following a multi-month breakout, with bullish trend signals supporting upside targets near key Fibonacci retracement resistance levels.
Locking In A Quick Gain In This Biotech ETF Made Room For Better Swing Trades; Here's Why
03:08pm, Friday, 01'st May 2026
Locking in profits while you have them can help avoid downturns.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
07:21am, Thursday, 30'th Apr 2026
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund lau
